Tue.Jul 01, 2025

article thumbnail

A New Era in Pharma DTC Marketing: Trust Over TV Spots

World of DTC Marketing

For decades, the image of pharmaceutical direct-to-consumer (DTC) marketing has been defined by glossy TV commercials: smiling patients, soft music, lengthy lists of side effects spoken at a rapid pace, and vague promises of a better life. But that era is quickly becoming obsolete. We’re entering a new era of pharma DTC marketing—one grounded not in big ad budgets and prime-time placement, but in trust, transparency, and easy-to-understand health information.

Marketing 251
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

In a quarterly update, the FDA said it’s evaluating the need for regulatory action on argenx’s Vyvgart Hytrulo after observing a potential signal of “severe worsening” of CIDP. But analysts are brushing off the risk.

FDA 258
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Overlooked Fix for Drug Affordability? Give People More Time to Pay

MedCity News

To make healthcare more affordable in the short term and the long run, time-to-pay must become an essential component of every health plan with any out-of-pocket responsibility. The post The Overlooked Fix for Drug Affordability? Give People More Time to Pay appeared first on MedCity News.

article thumbnail

AI’s ‘massive transition’ in biopharma shapes leadership mindsets — tension and all

PharmaVoice

The AI revolution is driving tension between new technology and the traditional approaches in drugmaking. Biopharma leaders are trying to navigate those turbulent waters.

Biopharma 173
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

MIT Spinout Syntis Bio Secures $33M for a Novel Approach to Treating Obesity and More

MedCity News

Instead of an engineered peptide to activate gut receptors to trigger metabolic effects, Syntis’s technology forms a coating in intestines that has the effect of redirecting nutrients, mimicking an effect of gastric bypass surgery. In other obesity medicine news, Protagonist Therapeutics revealed a drug candidate that puts it in competition with Novo Nordisk and Eli Lilly, among others.

article thumbnail

A biopharma doubles down on diversity goals through a newly created position

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Biopharma 130

More Trending

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

The U.S. Supreme Court ruled to protect a measure of the Affordable Care Act that supports preventative services such as pre-exposure prophylaxis (PrEP) HIV meds, offering good news for Gilead as it launches its long-acting PrEP drug Yeztugo.

143
143
article thumbnail

Lead Quality vs. Lead Volume: What Matters Most When Serving Vulnerable Populations

MedCity News

As scrutiny from CMS and the FCC increases, Medicare marketers must rethink how they source, verify, and engage leads. Taking the focus off lead volume and redirecting it to lead quality will help them demonstrate they run an ethical operation. The post Lead Quality vs. Lead Volume: What Matters Most When Serving Vulnerable Populations appeared first on MedCity News.

Leads 179
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Apellis and Sobi have amended their partnership agreement for paroxysmal nocturnal hemoglobinuria treatment Empaveli, or Aspaveli as it is known in Europe. With the new deal, Stockholm-based Sobi agreed to pay $275 million upfront and up to $25 million in potential milestones to reduce its ex-U.S. royalty obligations.

100
100
article thumbnail

Lilli Health Introduces App for Managing PCOS

MedCity News

The new Lilli App helps consumers manage polycystic ovary syndrome with meal plans, a symptom tracking tool and educational resources. The post Lilli Health Introduces App for Managing PCOS appeared first on MedCity News.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

KKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker into a fast-growing business for the past five years.

Pharma 107
article thumbnail

AbbVie's $2.1bn buy of Capstan lifts its immunology pipeline

pharmaphorum

Skip to main content Tuesday 1 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Whi

Media 65
article thumbnail

How Patient Advocacy Is Guiding Rare Disease Drug Development

Pharmaceutical Commerce

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how patient and caregiver insights shape drug development, regulatory decisions, and payer considerations in rare diseases.

article thumbnail

Novel pre-filled autoinjector receives EU approval

European Pharmaceutical Review

The European Commission has granted approval of the first subcutaneous, once-monthly octreotide for the rare, chronic disease acromegaly. Oczyesa ® (CAM2029), octreotide subcutaneous depot, is indicated as a maintenance treatment in adult patients who are responsive to and tolerate somatostatin analogs treatment. It is self-administered subcutaneously once-monthly via a pre-filled autoinjector pen.

Safety 52
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More

PharmaTech

Sascha Berger, private biopharmaceutical investor; Shannon Eaker, CTO of Xcellbio; Edwin Stone, CEO of Cellular Origins; and Bryce Sady, VP of Product Development at PSL Group go behind the headlines to talk CAR-T advancements, exciting M&A developments, and the impact of lost research funding on innovation.

52
article thumbnail

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

Pharmacy Times

CARTITUDE-1 trial reveals cilta-cel's potential in achieving long-term remission for relapsed/refractory multiple myeloma, sparking discussions on curative possibilities.

48
article thumbnail

Siemens Finalizes $5.1B Dotmatics Acquisition

PharmaTech

Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, and manufacturing digitally.

article thumbnail

Why Healthcare Marketing Analytics Just Got Harder (And What You Can Still Track)

Healthcare Success

AI Overviews were launched in the U.S. in May 2024, and their impact on analytics dashboards is still taking shape. While marketers and healthcare leaders have been busy speculatin g about their impact on organic traffic and brand visibility, Google isn’t offering much in the way of clarity. Tools like Google Analytics and Search Console still don’t show how often your brand appears in AI-generated answers (and that isn’t expected to change with AI Mode).

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Key Leaders at BIO 2025 Respond to Continuing Political Shifts

PharmaTech

In contrast to earlier conferences in 2025, experts interviewed as part of the BIO conference in Boston did not come to a consensus about lasting impacts of recent changes in US government policy.

article thumbnail

New medicine access times to be slashed under NHS plan

pharmaphorum

Reports suggest a new framework for medicine reviews and a push to reduce NHS reliance on overseas-trained staff will feature in the 10-year plan.

article thumbnail

Sanofi’s riliprubart gains ODD status from Japan’s MHLW for CIDP

Pharmaceutical Technology

Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.

52
article thumbnail

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes

Pharmacy Times

Obecabtagene autoleucel shows promising efficacy and safety in treating relapsed/refractory B-ALL, benefiting patients of all ages, including older adults.

Safety 35
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

PMI SOLOBAG™ joins the Specimen Retrieval Portfolio

Progressive Medical

PMI SOLOBAG™ Joins the PMI Specimen Retrieval Bag Family Your Choice, Our Commitment Progressive Medical, Inc. is proud to […] The post PMI SOLOBAG™ joins the Specimen Retrieval Portfolio appeared first on Progressive Medical, Inc.

Medical 52
article thumbnail

The One Thing Leaders Say Matters Most—And Invest in Least

ALULA

It is one of the oldest and most tragic truths of modern business: even though we know that people are the key to business success, we often fail to provide those people with what they need to succeed.

52
article thumbnail

7 Must-Have Features to Look for When Choosing a Field Sales CRM for Your Team

Toolyt

In the ever-evolving sales landscape, field reps are expected to close deals, manage follow-ups, and report progress—all while constantly being on the move. To meet these demands, companies must invest in the right field sales CRM features that empower on-the-go sales teams and streamline operations. Unlike traditional CRMs built for desk-based workflows, modern solutions like Toolyt are designed specifically for field sales reps—offering mobility, automation, and real-time visibility.

CRM 52
article thumbnail

Case-Based Insights on Managing Steroid-Refractory cGVHD After Haploidentical Transplant

Pharmacy Times

Gianni Scappaticci, PharmD, BCOP, outlines a personalized, evidence-based approach to managing steroid-refractory chronic graft-versus-host disease (cGVHD) in a post–haploidentical transplant patient, highlighting the rationale for using ruxolitinib, belumosudil, or their combination based on disease progression and fibrotic features.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Barriers are limiting UK childhood vaccination, say doctors

pharmaphorum

Skip to main content Tuesday 1 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Whi

Doctors 65
article thumbnail

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Pharmacy Times

Host Craig Beavers sits down with Kazuhiko Kido, PharmD, a clinical associate professor at the West Virginia University School of Pharmacy, to discuss intravenous iron and its use in patients with heart failure.

article thumbnail

Moderna flu vaccine shows superior results in phase 3 study

PharmaTimes

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Moderna flu vaccine shows superior results in phase 3 study by John Pinching | 1st Jul 2025 | News Data shows mRNA-1010 could better protect adults aged 50 and above Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose licensed influenza vac

Media 63
article thumbnail

Advancing Pharmacist Engagement in Biliary Tract Cancer: Disease State and Treatment Considerations

Pharmacy Times

Courtney Cavalieri, PharmD, BCOP, and Kenneth Tham, PharmD, BCOP, discuss how pharmacists play a crucial role in managing biliary tract cancer patients by providing expertise on biomarker testing, treatment selection between targeted therapies like FGFR and HER2 inhibitors, developing monitoring protocols for unique toxicities such as hyperphosphatemia, and educating patients on side effect management to optimize treatment outcomes in this rare cancer type.

article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.